[ORGANIZATION]
National Cancer Institute of Milan
Featured in 1 tracked story · first seen
Situations
Moderna and Merck melanoma vaccine clinical trials
3 clusters · 406 sources · last updated
Latest: Moderna and Merck mRNA melanoma vaccine shows success in phase 3 trial
Moderna and Merck (MSD) have reported positive Phase 3 clinical trial results for intismeran autogene (also known as V940 or mRNA-4157), an experimental personalized mRNA cancer vaccine. The therapy is designed to target